Cargando…
Screening and identification of emodin as an EBV DNase inhibitor to prevent its biological functions
BACKGROUND: The Epstein-Barr virus (EBV) is a prevalent oncovirus associated with a variety of human illnesses. BGLF5, an EBV DNase with alkaline nuclease (AN) activity, plays important roles in the viral life cycle and progression of human malignancies and has been suggested as a possible diagnosti...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339607/ https://www.ncbi.nlm.nih.gov/pubmed/37443068 http://dx.doi.org/10.1186/s12985-023-02107-x |
_version_ | 1785071883823087616 |
---|---|
author | Wu, Chung-Chun Chen, Mei-Shu Lee, Ting-Ying Cheng, Yu-Jhen Tsou, Hsiao-Hui Huang, Tze-Sing Cho, Der-Yang Chen, Jen-Yang |
author_facet | Wu, Chung-Chun Chen, Mei-Shu Lee, Ting-Ying Cheng, Yu-Jhen Tsou, Hsiao-Hui Huang, Tze-Sing Cho, Der-Yang Chen, Jen-Yang |
author_sort | Wu, Chung-Chun |
collection | PubMed |
description | BACKGROUND: The Epstein-Barr virus (EBV) is a prevalent oncovirus associated with a variety of human illnesses. BGLF5, an EBV DNase with alkaline nuclease (AN) activity, plays important roles in the viral life cycle and progression of human malignancies and has been suggested as a possible diagnostic marker and target for cancer therapy. Methods used conventionally for the detection of AN activity, radioactivity-based nuclease activity assay and DNA digestion detection by gel electrophoresis, are not suitable for screening AN inhibitors; the former approach is unsafe, and the latter is complicated. In the present study, a fluorescence-based nuclease activity assay was used to screen several natural compounds and identify an EBV DNase inhibitor. RESULTS: Fluorescence-based nuclease activity assays, in which the DNA substrate is labelled with PicoGreen dye, are cheaper, safer, and easier to perform. Herein, the results of the fluorescence-based nuclease activity assay were consistent with the results of the two conventional methods. In addition, the PicoGreen-labelling method was applied for the biochemical characterisation of viral nucleases. Using this approach, we explored EBV DNase inhibitors. After several rounds of screening, emodin, an anthraquinone derivative, was found to possess significant anti-EBV DNase activity. We verified the efficacy of emodin using the conventional DNA-cleavage assay. Furthermore, using comet assay and micronucleus formation detection, we confirmed that emodin can inhibit DNase-induced DNA damage and genomic instability. Additionally, emodin treatment inhibited EBV production. CONCLUSIONS: Using a PicoGreen-mediated nuclease activity assay, we successfully demonstrated that emodin has the potential to inhibit EBV DNase nuclease activity. Emodin also inhibits EBV DNase-related biological functions, suggesting that it is a potential inhibitor of EBV DNase. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12985-023-02107-x. |
format | Online Article Text |
id | pubmed-10339607 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-103396072023-07-14 Screening and identification of emodin as an EBV DNase inhibitor to prevent its biological functions Wu, Chung-Chun Chen, Mei-Shu Lee, Ting-Ying Cheng, Yu-Jhen Tsou, Hsiao-Hui Huang, Tze-Sing Cho, Der-Yang Chen, Jen-Yang Virol J Methodology BACKGROUND: The Epstein-Barr virus (EBV) is a prevalent oncovirus associated with a variety of human illnesses. BGLF5, an EBV DNase with alkaline nuclease (AN) activity, plays important roles in the viral life cycle and progression of human malignancies and has been suggested as a possible diagnostic marker and target for cancer therapy. Methods used conventionally for the detection of AN activity, radioactivity-based nuclease activity assay and DNA digestion detection by gel electrophoresis, are not suitable for screening AN inhibitors; the former approach is unsafe, and the latter is complicated. In the present study, a fluorescence-based nuclease activity assay was used to screen several natural compounds and identify an EBV DNase inhibitor. RESULTS: Fluorescence-based nuclease activity assays, in which the DNA substrate is labelled with PicoGreen dye, are cheaper, safer, and easier to perform. Herein, the results of the fluorescence-based nuclease activity assay were consistent with the results of the two conventional methods. In addition, the PicoGreen-labelling method was applied for the biochemical characterisation of viral nucleases. Using this approach, we explored EBV DNase inhibitors. After several rounds of screening, emodin, an anthraquinone derivative, was found to possess significant anti-EBV DNase activity. We verified the efficacy of emodin using the conventional DNA-cleavage assay. Furthermore, using comet assay and micronucleus formation detection, we confirmed that emodin can inhibit DNase-induced DNA damage and genomic instability. Additionally, emodin treatment inhibited EBV production. CONCLUSIONS: Using a PicoGreen-mediated nuclease activity assay, we successfully demonstrated that emodin has the potential to inhibit EBV DNase nuclease activity. Emodin also inhibits EBV DNase-related biological functions, suggesting that it is a potential inhibitor of EBV DNase. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12985-023-02107-x. BioMed Central 2023-07-13 /pmc/articles/PMC10339607/ /pubmed/37443068 http://dx.doi.org/10.1186/s12985-023-02107-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Methodology Wu, Chung-Chun Chen, Mei-Shu Lee, Ting-Ying Cheng, Yu-Jhen Tsou, Hsiao-Hui Huang, Tze-Sing Cho, Der-Yang Chen, Jen-Yang Screening and identification of emodin as an EBV DNase inhibitor to prevent its biological functions |
title | Screening and identification of emodin as an EBV DNase inhibitor to prevent its biological functions |
title_full | Screening and identification of emodin as an EBV DNase inhibitor to prevent its biological functions |
title_fullStr | Screening and identification of emodin as an EBV DNase inhibitor to prevent its biological functions |
title_full_unstemmed | Screening and identification of emodin as an EBV DNase inhibitor to prevent its biological functions |
title_short | Screening and identification of emodin as an EBV DNase inhibitor to prevent its biological functions |
title_sort | screening and identification of emodin as an ebv dnase inhibitor to prevent its biological functions |
topic | Methodology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339607/ https://www.ncbi.nlm.nih.gov/pubmed/37443068 http://dx.doi.org/10.1186/s12985-023-02107-x |
work_keys_str_mv | AT wuchungchun screeningandidentificationofemodinasanebvdnaseinhibitortopreventitsbiologicalfunctions AT chenmeishu screeningandidentificationofemodinasanebvdnaseinhibitortopreventitsbiologicalfunctions AT leetingying screeningandidentificationofemodinasanebvdnaseinhibitortopreventitsbiologicalfunctions AT chengyujhen screeningandidentificationofemodinasanebvdnaseinhibitortopreventitsbiologicalfunctions AT tsouhsiaohui screeningandidentificationofemodinasanebvdnaseinhibitortopreventitsbiologicalfunctions AT huangtzesing screeningandidentificationofemodinasanebvdnaseinhibitortopreventitsbiologicalfunctions AT choderyang screeningandidentificationofemodinasanebvdnaseinhibitortopreventitsbiologicalfunctions AT chenjenyang screeningandidentificationofemodinasanebvdnaseinhibitortopreventitsbiologicalfunctions |